American Shared Hospital Services (NYSEAMERICAN:AMS) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

American Shared Hospital Services (NYSEAMERICAN:AMS) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.00 and traded as high as $2.77. American Shared Hospital Services shares last traded at $2.75, with a volume of 9,420 shares.

Analysts Set New Price Targets

Separately, StockNews.com initiated coverage on shares of American Shared Hospital Services in a research note on Tuesday, January 14th. They set a “hold” rating for the company.

American Shared Hospital Services Stock Performance

The company has a market capitalization of $17.66 million, a P/E ratio of 4.58 and a beta of 0.66. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.34.

Institutional Trading of American Shared Hospital Services

A hedge fund recently raised its stake in American Shared Hospital Services stock. Renaissance Technologies LLC raised its position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) by 5.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 71,225 shares of the company’s stock after buying an additional 3,776 shares during the period. Renaissance Technologies LLC owned about 1.11% of American Shared Hospital Services worth $227,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 23.16% of the company’s stock.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.